Huaxia Eye Hospital Group Co.,Ltd.

SZSE:301267 Stock Report

Market Cap: CN¥14.6b

Huaxia Eye Hospital GroupLtd Management

Management criteria checks 2/4

Huaxia Eye Hospital GroupLtd's CEO is Qingcan Su, appointed in Dec 2015, has a tenure of 9.17 years. directly owns 61.33% of the company’s shares, worth CN¥8.98B. The average tenure of the management team and the board of directors is 5.2 years and 2.9 years respectively.

Key information

Qingcan Su

Chief executive officer

CN¥641.1k

Total compensation

CEO salary percentagen/a
CEO tenure9.2yrs
CEO ownership61.3%
Management average tenure5.2yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

Is Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) Expensive For A Reason? A Look At Its Intrinsic Value

Dec 23
Is Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) Expensive For A Reason? A Look At Its Intrinsic Value

Here's What's Concerning About Huaxia Eye Hospital GroupLtd's (SZSE:301267) Returns On Capital

Oct 28
Here's What's Concerning About Huaxia Eye Hospital GroupLtd's (SZSE:301267) Returns On Capital

Huaxia Eye Hospital Group Co.,Ltd.'s (SZSE:301267) 43% Price Boost Is Out Of Tune With Earnings

Sep 30
Huaxia Eye Hospital Group Co.,Ltd.'s (SZSE:301267) 43% Price Boost Is Out Of Tune With Earnings

Huaxia Eye Hospital GroupLtd's (SZSE:301267) Conservative Accounting Might Explain Soft Earnings

Sep 04
Huaxia Eye Hospital GroupLtd's (SZSE:301267) Conservative Accounting Might Explain Soft Earnings

Does Huaxia Eye Hospital GroupLtd (SZSE:301267) Have A Healthy Balance Sheet?

Aug 19
Does Huaxia Eye Hospital GroupLtd (SZSE:301267) Have A Healthy Balance Sheet?

Huaxia Eye Hospital GroupLtd's (SZSE:301267) Dividend Is Being Reduced To CN¥0.11

Jul 12
Huaxia Eye Hospital GroupLtd's (SZSE:301267) Dividend Is Being Reduced To CN¥0.11

Huaxia Eye Hospital GroupLtd (SZSE:301267) Has Some Way To Go To Become A Multi-Bagger

Jun 06
Huaxia Eye Hospital GroupLtd (SZSE:301267) Has Some Way To Go To Become A Multi-Bagger

Analysts Just Shaved Their Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) Forecasts Dramatically

May 01
Analysts Just Shaved Their Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) Forecasts Dramatically

Huaxia Eye Hospital GroupLtd (SZSE:301267) Seems To Use Debt Rather Sparingly

Feb 29
Huaxia Eye Hospital GroupLtd (SZSE:301267) Seems To Use Debt Rather Sparingly

CEO

Qingcan Su (55 yo)

9.2yrs

Tenure

CN¥641,100

Compensation

Mr. Qingcan Su is Chairman of the Board & General Manager of Huaxia Eye Hospital Group Co.,Ltd. from December 29, 2015.

Leadership Team

NamePositionTenureCompensationOwnership
Qingcan Su
Chairman of the Board & GM9.2yrsCN¥641.10k61.33%
CN¥ 9.0b
Lu Yan Chen
Financial Director & Accounting Supervisor5.2yrsCN¥604.50kno data
Xiaofeng Li
Deputy GM & Non-Independent Director5.2yrsCN¥843.30kno data
Nai En Cao
Board Secretary5.2yrsCN¥607.00kno data

5.2yrs

Average Tenure

50.5yo

Average Age

Experienced Management: 301267's management team is seasoned and experienced (5.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Qingcan Su
Chairman of the Board & GM9.2yrsCN¥641.10k61.33%
CN¥ 9.0b
Xiaofeng Li
Deputy GM & Non-Independent Director2.2yrsCN¥843.30kno data
Fengguo Chen
Director5.2yrsCN¥852.90kno data
Guangbin Zhang
Non-Independent Director2.2yrsCN¥1.65m0.00018%
CN¥ 26.4k
Zhiqiang Wang
Independent Director2.2yrsCN¥80.00kno data
Wenli Zheng
Independent Director2.2yrsCN¥80.00kno data
Jun Hu
Independent Director2.9yrsCN¥80.00kno data
Niya Huang
Supervisor5.2yrsno datano data
Xiulian Zhang
Supervisor5.2yrsno datano data

2.9yrs

Average Tenure

57yo

Average Age

Experienced Board: 301267's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 07:29
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Huaxia Eye Hospital Group Co.,Ltd. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yichi ZhangChina International Capital Corporation Limited
null nullChina International Capital Corporation Limited
Shuo SongCitic Securities Co., Ltd.